Published in Br Med J (Clin Res Ed) on October 08, 1983
Ketanserin in essential hypertension: a double-blind, placebo-controlled study. Postgrad Med J (1985) 1.32
Controlled trial of ketanserin in hypertension. Br J Clin Pharmacol (1985) 0.95
In vivo and in vitro activity of selective 5-hydroxytryptamine2 receptor antagonists. Br J Pharmacol (1986) 0.79
Effect of the 5-hydroxytryptamine type 2 receptor antagonist, ketanserin, on blood pressure, the renin-angiotensin system and sympatho-adrenal function in patients with essential hypertension. Br J Clin Pharmacol (1984) 0.75
Is ketanserin a D receptor antagonist? Lancet (1983) 1.69
Captopril in the treatment of clinical hypertension and cardiac failure. Lancet (1979) 3.93
Examination of clinical examiners. Lancet (1969) 3.07
Factors related to first dose hypotensive effect of captopril: prediction and treatment. Br Med J (Clin Res Ed) (1983) 2.90
Recent progress toward understanding biosynthesis of the amylopectin crystal. Plant Physiol (2000) 2.87
Captopril in heart failure. A double blind controlled trial. Br Heart J (1984) 2.85
Effects of enalapril in heart failure: a double blind study of effects on exercise performance, renal function, hormones, and metabolic state. Br Heart J (1985) 2.74
The codon 620 tryptophan allele of the lymphoid tyrosine phosphatase (LYP) gene is a major determinant of Graves' disease. J Clin Endocrinol Metab (2004) 2.44
Renin relationships in congestive cardiac failure, treated and untreated. Am Heart J (1970) 2.33
Treatment of phaeochromocytoma and of clonidine withdrawal hypertension with labetalol. Br J Clin Pharmacol (1976) 2.25
Severe hypotension after first dose of enalapril in heart failure. Br Med J (Clin Res Ed) (1985) 2.14
Hypertension with aldosterone excess and low plasma-renin: preoperative distinction between patients with and without adrenocortical tumour. Lancet (1970) 1.90
Radio-immunoassay for plasma alpha human atrial natriuretic peptide: a comparison of direct and pre-extracted methods. J Hypertens (1987) 1.90
The estimation of renin in human plasma. Biochem J (1964) 1.85
Plasma Renin Concentration in Human Hypertension-III: Renin in Relation to Complications of Hypertension. Br Med J (1966) 1.83
Beta cell differentiation during early human pancreas development. J Endocrinol (2004) 1.82
Captopril in renovascular hypertension: long-term use in predicting surgical outcome. Br Med J (Clin Res Ed) (1982) 1.76
Circulating dopamine: its effect on the plasma concentrations of catecholamines, renin, angiotensin, aldosterone and vasopressin in the conscious dog. Clin Sci (Lond) (1981) 1.76
"Third drug" trial: comparative study of antihypertensive agents added to treatment when blood pressure remains uncontrolled by a beta blocker plus thiazide diuretic. Br Med J (Clin Res Ed) (1984) 1.69
Captopril: five years on. Br Med J (Clin Res Ed) (1983) 1.68
Severe hyponatraemia. A study of 17 patients. Lancet (1978) 1.68
Combined treatment of severe intractable hypertension with captopril and diuretic. Lancet (1980) 1.68
Splice variants reveal the region involved in oxygen sensing by recombinant human L-type Ca(2+) channels. Circ Res (2000) 1.66
Renin and acute renal failure: studies in man. Br Med J (1970) 1.66
Letter: Effect of skin-cleaning agents on Dextrostix readings. Br Med J (1976) 1.61
An evaluation of the beta-1 adrenergic receptor Arg389Gly polymorphism in individuals at risk of coronary events. A WOSCOPS substudy. Eur Heart J (2002) 1.61
Angiotensin II, aldosterone and arterial pressure: a quantitative approach. Arthur C. Corcoran Memorial Lecture. Hypertension (1980) 1.60
The estimation of renin in plasma by an enzyme kinetic technique. Biochem J (1964) 1.56
Effect of ramipril on morbidity and mode of death among survivors of acute myocardial infarction with clinical evidence of heart failure. A report from the AIRE Study Investigators. Eur Heart J (1997) 1.54
Salt and hypertension. Lancet (1984) 1.52
QT dispersion as a predictor of long-term mortality in patients with acute myocardial infarction and clinical evidence of heart failure. Eur Heart J (1999) 1.51
Psychiatric disturbance leading to potassium depletion, sodium depletion, raised plasma-renin concentration, and secondary hyperaldosteronism. Lancet (1968) 1.49
Effect of a common X-linked angiotensin II type 2-receptor gene polymorphism (-1332 G/A) on the occurrence of premature myocardial infarction and stenotic atherosclerosis requiring revascularization. Atherosclerosis (2007) 1.48
ACE inhibitors for myocardial infarction and unstable angina. Lancet (1993) 1.47
Ribosomal protein L3 is involved in replication or maintenance of the killer double-stranded RNA genome of Saccharomyces cerevisiae. Proc Natl Acad Sci U S A (1982) 1.46
Hyponatremia following mild/moderate subarachnoid hemorrhage is due to SIAD and glucocorticoid deficiency and not cerebral salt wasting. J Clin Endocrinol Metab (2013) 1.46
Renin and angiotensin. A survey of some aspects. Postgrad Med J (1966) 1.45
Neurobiology of depression: an integrated view of key findings. Int J Clin Pract (2007) 1.44
Plasma alpha natriuretic peptide in cardiac impairment. Br Med J (Clin Res Ed) (1986) 1.44
Dietary salt and essential hypertension. Lancet (1996) 1.40
Overdiagnosis of hypertension in the elderly. J Hum Hypertens (1992) 1.39
Excess smoking in malignant-phase hypertension. Br Med J (1979) 1.38
Letter: Intravenous labetalol in severe hypertension. Lancet (1975) 1.37
Long-term effects of neonatal sodium restriction on blood pressure. Am J Hypertens (1997) 1.37
Acute renal failure, tubular necrosis, and myocardial infarction induced in the rabbit by intravenous angiotensin II. Lancet (1971) 1.37
Hyponatraemic hypertensive syndrome with renal-artery occlusion corrected by captopril. Lancet (1979) 1.37
Common polymorphisms of beta1-adrenoceptor: identification and rapid screening assay. Lancet (1999) 1.36
Water intoxication associated with carbamazepine treatment. Br Med J (1977) 1.35
Concurrent estimation of total body and exchangeable body sodium in hypertension. Clin Sci Mol Med (1978) 1.34
Plasma renin concentration and the control of blood pressure in patients on maintenance haemodialysis. Nephron (1969) 1.33
Results of adrenal surgery in patients with hypertension, aldosterone excess, and low plasma renin concentration. Br Med J (1975) 1.32
Microangiopathic haemolytic anaemia and the pathogenesis of malignant hypertension. Lancet (1969) 1.31
Renin and angiotensin as a mechanism of diuretic-induced antidiuresis in diabetes insipidus. Lancet (1969) 1.30
Severe hypokalaemia with paralysis induced by small doses of liquorice. Postgrad Med J (1980) 1.29
Hypoxia inhibits the recombinant alpha 1C subunit of the human cardiac L-type Ca2+ channel. J Physiol (1997) 1.29
The effect of carbidopa administration on urinary sodium excretion in man. Is dopamine an intrarenal natriuretic hormone? Br J Clin Pharmacol (1977) 1.24
Expression of steroidogenic factor 1 and Wilms' tumour 1 during early human gonadal development and sex determination. Mech Dev (1999) 1.24
Effect of blood pressure angiotensin II and aldosterone concentrations during treatment of severe hypertension with intravenous labetalol: comparison with propranolol. Br J Clin Pharmacol (1976) 1.22
Urinary dopamine in man and rat: effects of inorganic salts on dopamine excretion. Clin Sci Mol Med (1978) 1.22
Modulation of recombinant human cardiac L-type Ca2+ channel alpha1C subunits by redox agents and hypoxia. J Physiol (1999) 1.21
Neurological dysfunction in two patients receiving captopril and cimetidine. Lancet (1980) 1.20
Coordinate regulation of glycogen metabolism in the yeast Saccharomyces cerevisiae. Induction of glycogen branching enzyme. J Biol Chem (1992) 1.20
Novel SOX9 expression during human pancreas development correlates to abnormalities in Campomelic dysplasia. Mech Dev (2002) 1.20
Safety and diagnostic accuracy of stress cardiac magnetic resonance imaging vs exercise tolerance testing early after acute ST elevation myocardial infarction. Heart (2007) 1.20
Captopril treatment: inter-dose variations in renin, angiotensins I and II, aldosterone and blood pressure. Br J Clin Pharmacol (1982) 1.19
Plasma renin concentration in human hypertension . II. Renin in relation to aetiology. Br Med J (1965) 1.19
Sodium and potassium in essential hypertension. Br Med J (Clin Res Ed) (1981) 1.18
Is low-renin hypertension a stage in the development of essential hypertension or a diagnostic entity? Lancet (1975) 1.18
Biochemical characterization of wild-type and mutant isoamylases of Chlamydomonas reinhardtii supports a function of the multimeric enzyme organization in amylopectin maturation. Plant Physiol (2001) 1.18
Plasma renin, renin substrate, angiotensin II, and aldosterone in hypertensive disease of pregnancy. Lancet (1973) 1.18
ACE inhibitors after myocardial infarction. Lancet (1994) 1.17
Expression profiles of SF-1, DAX1, and CYP17 in the human fetal adrenal gland: potential interactions in gene regulation. Mol Endocrinol (2001) 1.17
Sensitization of the adrenal cortex to angiotensin II in sodium-deplete man. Circ Res (1974) 1.15
The relation of arterial pressure and plasma angiotensin II concentration. A change produced by prolonged infusion of angiotensin II in the conscious dog. Circ Res (1979) 1.15
Two loci control phytoglycogen production in the monocellular green alga Chlamydomonas reinhardtii. Plant Physiol (2001) 1.13
Reconstructive surgery versus nephrectomy in renal artery stenosis: comparison of effects on total and divided renal function and on blood pressure. Br Med J (1980) 1.13
Converting enzyme inhibitors in hypertension and heart failure. Br Heart J (1983) 1.12
Diuretic-induced potassium and magnesium deficiency: relation to drug-induced QT prolongation, cardiac arrhythmias and sudden death. J Hypertens (1992) 1.12
Quadric analysis in the preoperative distinction between patients with and without adrenocortical tumors in hypertension with aldosterone excess and low plasma renin. Am Heart J (1971) 1.11
Enalapril (MK421) and its lysine analogue (MK521): a comparison of acute and chronic effects on blood pressure, renin-angiotensin system and sodium excretion in normal man. Br J Clin Pharmacol (1984) 1.10
Plasma-renin and aldosterone secretion in hypertensive patients with renal or renal artery lesions. Lancet (1965) 1.10
Enalapril (MK421) in the treatment of hypertension with renal artery stenosis. J Hypertens Suppl (1983) 1.09
Renin, angiotensin and aldosterone in human pregnancy and the menstrual cycle. Scott Med J (1971) 1.08
Renin in diabetes insipidus. Lancet (1965) 1.08
Effect of angiotensin and of frusemide on plasma aldosterone, corticosterone, cortisol and renin in man. Lancet (1965) 1.08
Hypertension and chronic renal failure. Br Med Bull (1971) 1.07
The heart failure revascularisation trial (HEART): rationale, design and methodology. Eur J Heart Fail (2003) 1.07
Thrombolysis: too old and too young. Heart (2002) 1.06
Total body electrolyte composition in patients with heart failure: a comparison with normal subjects and patients with untreated hypertension. Br Heart J (1987) 1.06
Angiotensin- and norepinephrine-induced myocardial lesions: experimental and clinical studies in rabbits and man. Am Heart J (1975) 1.05
Cough and angiotensin converting enzyme inhibition. Br Med J (Clin Res Ed) (1988) 1.04
Captopril, angiotensin II, and sodium in blood-pressure regulation. Lancet (1979) 1.04
The Acute Infarction Ramipril Efficacy (AIRE) Study: rationale, design, organization, and outcome definitions. J Cardiovasc Pharmacol (1991) 1.04